JAMDA
May 25, 2023
Showing 81 - 90 of 2516 results
JAMDA
February 27, 2022
Greater Opioid Use Among Nursing Home Residents in Ontario, Canada During the First 2 Waves of the COVID-19 Pandemic
To examine the association between the COVID-19 pandemic and opioid use among nursing home residents followed up to March 2021, and possible variation by dementia and frailty status.
JAMDA
October 7, 2021
Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes
This study evaluated logistics, process data, and barriers/facilitators for the implementation and use of C-reactive protein point-of-care testing (CRP POCT) for suspected lower respiratory tract infections (LRTIs) in nursing home (NH) residents.
JAMDA
January 25, 2019
Standards for the Use of Telemedicine for Evaluation and Management of Resident Change of Condition in the Nursing Home
This document offers guidance to clinicians and facilities on the use of telemedicine to deliver medically necessary evaluation and management of change of condition for nursing home residents.
JAMDA
July 31, 2015
The Effect of Depressive Symptoms and Antidepressant Use on Subsequent Physical Decline and Number of Hospitalizations in Nursing Home Residents: A 9-Year Longitudinal Study
To investigate whether depressive symptoms and antidepressant use at baseline predict the subsequent decline in physical functioning and number of hospitalizations in nursing home residents.
JAMDA
October 14, 2016
Prevalence of Antimicrobial Use and Opportunities to Improve Prescribing Practices in U.S. Nursing Homes
To describe the prevalence and epidemiology of antimicrobial use (AU) in nursing home residents.
JAMDA
December 8, 2019
Epidemiology of Antibiotic Use for Urinary Tract Infection in Nursing Home Residents
Describe antibiotic use for urinary tract infection (UTI) among a large cohort of US nursing home residents.
JAMDA
August 5, 2023
Use of Diabetes Medications before and after a Heart Failure–Related Hospitalization among Nursing Home Residents
Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiovascular benefits, whereas thiazolidinediones (TZDs) and sulfonylureas (SUs) increase cardiovascular risk. The objective of this study was to describe the use of SGLT-2is, GLP-1RAs, TZD...
JAMDA
January 30, 2024
Sliding Scale Insulin Use in Nursing Homes Before and After Onset of the COVID-19 Pandemic
To characterize sliding-scale insulin (SSI) use in US nursing homes (NHs) before and after the COVID-19 pandemic.
JAMDA
January 15, 2021